These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 30387392

  • 41. Alkaloids of Amaryllidaceae as Inhibitors of Cholinesterases (AChEs and BChEs): An Integrated Bioguided Study.
    Cortes N, Sierra K, Alzate F, Osorio EH, Osorio E.
    Phytochem Anal; 2018 Mar; 29(2):217-227. PubMed ID: 29044771
    [Abstract] [Full Text] [Related]

  • 42. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease.
    Anand P, Singh B, Singh N.
    Bioorg Med Chem; 2012 Feb 01; 20(3):1175-80. PubMed ID: 22257528
    [Abstract] [Full Text] [Related]

  • 43. In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer's Disease.
    Iman K, Mirza MU, Mazhar N, Vanmeert M, Irshad I, Kamal MA.
    CNS Neurol Disord Drug Targets; 2018 Apr 26; 17(1):54-68. PubMed ID: 29336270
    [Abstract] [Full Text] [Related]

  • 44. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
    Karaman N, Sıcak Y, Taşkın-Tok T, Öztürk M, Karaküçük-İyidoğan A, Dikmen M, Koçyiğit-Kaymakçıoğlu B, Oruç-Emre EE.
    Eur J Med Chem; 2016 Nov 29; 124():270-283. PubMed ID: 27592396
    [Abstract] [Full Text] [Related]

  • 45. Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer's disease.
    Huang L, Miao H, Sun Y, Meng F, Li X.
    Eur J Med Chem; 2014 Nov 24; 87():429-39. PubMed ID: 25282266
    [Abstract] [Full Text] [Related]

  • 46. Potential anti-cholinesterase and β-site amyloid precursor protein cleaving enzyme 1 inhibitory activities of cornuside and gallotannins from Cornus officinalis fruits.
    Bhakta HK, Park CH, Yokozawa T, Tanaka T, Jung HA, Choi JS.
    Arch Pharm Res; 2017 Jul 24; 40(7):836-853. PubMed ID: 28589255
    [Abstract] [Full Text] [Related]

  • 47. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents.
    Luo W, Su YB, Hong C, Tian RG, Su LP, Wang YQ, Li Y, Yue JJ, Wang CJ.
    Bioorg Med Chem; 2013 Dec 01; 21(23):7275-82. PubMed ID: 24148835
    [Abstract] [Full Text] [Related]

  • 48. Phthalimide-Derived N-Benzylpyridinium Halides Targeting Cholinesterases: Synthesis and Bioactivity of New Potential Anti-Alzheimer's Disease Agents.
    Saeedi M, Golipoor M, Mahdavi M, Moradi A, Nadri H, Emami S, Foroumadi A, Shafiee A.
    Arch Pharm (Weinheim); 2016 Apr 01; 349(4):293-301. PubMed ID: 26898241
    [Abstract] [Full Text] [Related]

  • 49. Rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
    Wang ZM, Cai P, Liu QH, Xu DQ, Yang XL, Wu JJ, Kong LY, Wang XB.
    Eur J Med Chem; 2016 Nov 10; 123():282-297. PubMed ID: 27484514
    [Abstract] [Full Text] [Related]

  • 50. Anti-Alzheimers activity and molecular mechanism of albumin-derived peptides against AChE and BChE.
    Yu Z, Wu S, Zhao W, Ding L, Fan Y, Shiuan D, Liu J, Chen F.
    Food Funct; 2018 Feb 21; 9(2):1173-1178. PubMed ID: 29363710
    [Abstract] [Full Text] [Related]

  • 51. An Efficient Synthesis of bi-Aryl Pyrimidine Heterocycles: Potential New Drug Candidates to Treat Alzheimer's Disease.
    Rehman TU, Khan IU, Ashraf M, Tarazi H, Riaz S, Yar M.
    Arch Pharm (Weinheim); 2017 Apr 21; 350(3-4):. PubMed ID: 28220522
    [Abstract] [Full Text] [Related]

  • 52. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.
    Li RS, Wang XB, Hu XJ, Kong LY.
    Bioorg Med Chem Lett; 2013 May 01; 23(9):2636-41. PubMed ID: 23511019
    [Abstract] [Full Text] [Related]

  • 53. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
    Pacheco G, Palacios-Esquivel R, Moss DE.
    J Pharmacol Exp Ther; 1995 Aug 01; 274(2):767-70. PubMed ID: 7636741
    [Abstract] [Full Text] [Related]

  • 54. Tetrahydroacridine derivatives with dichloronicotinic acid moiety as attractive, multipotent agents for Alzheimer's disease treatment.
    Czarnecka K, Chufarova N, Halczuk K, Maciejewska K, Girek M, Skibiński R, Jończyk J, Bajda M, Kabziński J, Majsterek I, Szymański P.
    Eur J Med Chem; 2018 Feb 10; 145():760-769. PubMed ID: 29353726
    [Abstract] [Full Text] [Related]

  • 55. Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics.
    Makhaeva GF, Boltneva NP, Lushchekina SV, Rudakova EV, Serebryakova OG, Kulikova LN, Beloglazkin AA, Borisov RS, Richardson RJ.
    Bioorg Med Chem; 2018 Sep 01; 26(16):4716-4725. PubMed ID: 30104121
    [Abstract] [Full Text] [Related]

  • 56. Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.
    Korabecny J, Musilek K, Holas O, Binder J, Zemek F, Marek J, Pohanka M, Opletalova V, Dohnal V, Kuca K.
    Bioorg Med Chem Lett; 2010 Oct 15; 20(20):6093-5. PubMed ID: 20817518
    [Abstract] [Full Text] [Related]

  • 57. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents.
    Ambure P, Kar S, Roy K.
    Biosystems; 2014 Feb 15; 116():10-20. PubMed ID: 24325852
    [Abstract] [Full Text] [Related]

  • 58. Synthesis and biological activity of new donepezil-hydrazinonicotinamide hybrids.
    Zurek E, Szymański P, Mikiciuk-Olasik E.
    Drug Res (Stuttg); 2013 Mar 15; 63(3):137-44. PubMed ID: 23447117
    [Abstract] [Full Text] [Related]

  • 59. Synthesis and biological evaluation of 3-(4-aminophenyl)-coumarin derivatives as potential anti-Alzheimer's disease agents.
    Hu YH, Yang J, Zhang Y, Liu KC, Liu T, Sun J, Wang XJ.
    J Enzyme Inhib Med Chem; 2019 Dec 15; 34(1):1083-1092. PubMed ID: 31117844
    [Abstract] [Full Text] [Related]

  • 60. Design, synthesis and biological evaluation of benzylisoquinoline derivatives as multifunctional agents against Alzheimer's disease.
    Xu ZC, Wang XB, Yu WY, Xie SS, Li SY, Kong LY.
    Bioorg Med Chem Lett; 2014 May 15; 24(10):2368-73. PubMed ID: 24726809
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.